Fresenius Medical Care (NYSE:FMS) Sees Unusually-High Trading Volume - Time to Buy?

Fresenius Medical Care AG (NYSE:FMS - Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 740,733 shares traded hands during mid-day trading, an increase of 138% from the previous session's volume of 310,951 shares.The stock last traded at $24.66 and had previously closed at $24.47.

Analysts Set New Price Targets

FMS has been the topic of a number of analyst reports. StockNews.com raised shares of Fresenius Medical Care from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 5th. Bank of America upgraded shares of Fresenius Medical Care from an "underperform" rating to a "neutral" rating in a report on Monday, December 2nd. Finally, Truist Financial increased their price objective on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the company a "hold" rating in a research note on Monday, January 6th.

Fresenius Medical Care Price Performance

The stock has a market cap of $14.25 billion, a P/E ratio of 20.07, a P/E/G ratio of 0.76 and a beta of 0.99. The business has a 50 day simple moving average of $23.86 and a 200-day simple moving average of $22.37. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.02 and a current ratio of 1.37.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of FMS. Venturi Wealth Management LLC lifted its stake in Fresenius Medical Care by 8.4% in the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company's stock valued at $129,000 after purchasing an additional 441 shares during the last quarter. PNC Financial Services Group Inc. lifted its position in shares of Fresenius Medical Care by 5.0% during the 4th quarter. PNC Financial Services Group Inc. now owns 9,278 shares of the company's stock valued at $210,000 after buying an additional 442 shares during the last quarter. MML Investors Services LLC grew its stake in shares of Fresenius Medical Care by 5.3% during the 3rd quarter. MML Investors Services LLC now owns 15,019 shares of the company's stock worth $320,000 after acquiring an additional 753 shares during the period. Smartleaf Asset Management LLC increased its holdings in Fresenius Medical Care by 192.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock worth $28,000 after acquiring an additional 806 shares during the last quarter. Finally, DAVENPORT & Co LLC raised its stake in Fresenius Medical Care by 1.5% in the 4th quarter. DAVENPORT & Co LLC now owns 58,147 shares of the company's stock valued at $1,316,000 after acquiring an additional 862 shares during the period. 8.37% of the stock is owned by institutional investors.

Remove Ads

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.